Topotecan versus paclitaxel in second-line therapy: A lost opportunity for quality-of-life evaluation? (multiple letter) [1]

G. Apolone, A. Buda, Graham A. Ross, J. A. Kettels

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1443-1444
Number of pages2
JournalAnnals of Oncology
Issue number9
Publication statusPublished - Sep 2004

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this